Genevoyager
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 2
About Genevoyager
Based in Wuhan, China, and established in 2022, Genevoyager is a biotechnology company that engages in the development of large-scale viral vector production and delivery technology. The company also is a one-stop contract research organization (CRO) or contract development and manufacturing organization (CDMO) service for gene therapy drugs. The company's R&D team members with master's and doctoral degrees account for 70% of employees., a CRO company providing customized viral packing services over the past 9 years., a CDMO company, can produce large-scale Adeno-associated viruses AAV gene therapy drugs. The company provides CRO services, including one-stop services for new drug non-clinical evaluation, drug screening, Adeno-associated viruses (AAV) service, oncolytic viruses services, stem cell services, and protein and VLP services. The company also provides CDMO services, including AAV CDMO services, cell banking, virus seed banking, AAV non-GMP production, AAV-GMP production, oncolytic virus modification, and protein or virus-like particles (VLP) CDMO services.0 system, molecular cloning and screening platforms, animal disease model construction platforms, and neutralizing antibody detection platforms.
Who invested in Genevoyager
2 investors across 1 round
See all investors in Genevoyager
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 29, 2023
Amount
Undisclosed
Investors
Questions about Genevoyager
Who invested in Genevoyager?
Genevoyager has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genevoyager raised?
Genevoyager has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Genevoyager last raise money?
Genevoyager's most recent round on record is a Series A, in Aug 2023.
What does Genevoyager do?
Based in Wuhan, China, and established in 2022, Genevoyager is a biotechnology company that engages in the development of large-scale viral vector production and delivery technology.
Where is Genevoyager headquartered?
Genevoyager is headquartered in Wuhan, China.
Which VCs invest in companies like Genevoyager?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genevoyager's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genevoyager? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.